Stable expression of human kinin B-1 receptor in 293 cells: pharmacological and functional characterization

被引:37
作者
Bastian, S
Loillier, B
Paquet, JL
Pruneau, D
机构
[1] Centre de Recherche, Laboratoires Fournier S.A., 21121-Daix
关键词
kinin B-1 receptor; binding; phosphoinositosides cascade; calcium;
D O I
10.1038/sj.bjp.0701380
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We compared the binding properties of [H-3]-desArg(10)-[Leu(9)]-kallidin, a radiolabelled kinin B-1 receptor antagonist, to membranes from IMR-90 human embryonic fibroblasts and from 293 cells transiently or stably transfected with the human B-1 receptor. 2 The dissociation constant (K-D) of [H-3]-desArg(10)-[Leu(9)]-kallidin and the affinity of several kinin receptor agonists and antagonists were similar between the native and cloned receptor, either transiently or stably expressed in 293 cells. In IMR-90 cells, the rank order of potency was that expected for a kinin B-1 receptor. 3 The receptors transiently or stably expressed in 293 cells were fully functional with respect to their signalling properties. Phosphoinositide hydrolysis was increased in a concentration-dependent manner by the B-1 receptor agonist, desArg(10)-kallidin. Functional coupling to the calcium pathway was also demonstrated for the native and stably expressed human B-1 receptor. 4 In conclusion, the established stable and functional 293 cell clone may provide an important tool for further analysis of the molecular mechanisms involved in binding, activation, and coupling of the kinin B-1 receptor.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 35 条
[1]   LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
BIOCHEMICAL JOURNAL, 1982, 206 (03) :587-595
[2]   STUDIES ON THE INDUCTION OF PHARMACOLOGICAL RESPONSES TO DES-ARG9-BRADYKININ INVITRO AND INVIVO [J].
BOUTHILLIER, J ;
DEBLOIS, D ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (02) :257-264
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Comparative profile of novel potent bradykinin antagonists at human B-1 and B-2 receptors [J].
Burkard, M ;
Zuzack, JS ;
Jones, S ;
Francis, M ;
Walley, ET ;
Stewart, JM ;
Gera, L .
IMMUNOPHARMACOLOGY, 1996, 33 (1-3) :186-190
[5]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[6]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[7]   EFFECT OF GLUCOCORTICOIDS, MONOKINES AND GROWTH-FACTORS ON THE SPONTANEOUSLY DEVELOPING RESPONSES OF THE RABBIT ISOLATED AORTA TO DES-ARG9-BRADYKININ [J].
DEBLOIS, D ;
BOUTHILLIER, J ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :969-977
[8]  
DRAPEAU G, 1991, J PHARMACOL EXP THER, V259, P997
[9]   BRADYKININ AND INFLAMMATORY PAIN [J].
DRAY, A ;
PERKINS, M .
TRENDS IN NEUROSCIENCES, 1993, 16 (03) :99-104
[10]   UP-REGULATION OF [H-3] DES-ARG(10)-KALLIDIN BINDING TO THE BRADYKININ B-1 RECEPTOR BY INTERLEUKIN-1-BETA IN ISOLATED SMOOTH-MUSCLE CELLS - CORRELATION WITH B-1 AGONIST-INDUCED PGI(2) PRODUCTION [J].
GALIZZI, JP ;
BODINIER, MC ;
CHAPELAIN, B ;
LY, SM ;
COUSSY, L ;
GIRAUD, S ;
NELIAT, G ;
JEAN, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (02) :389-394